most common forms of chronic liver disease which may progress to non-alcoholic steatohepatitis (NASH). Currently there are no therapeutic strategies for such disease. Only lifestyle modification through diet
most common forms of chronic liver disease which may progress to non-alcoholic steatohepatitis (NASH). Currently there are no therapeutic strategies for such disease. Only lifestyle modification through diet
alcoholic steatohepatitis (NASH) is the most common chronic liver disease in the world, characterized by the hepatic steatosis, inflammation, hepatocyte injury with or without fibrogenesis, which might lead to cirrhosis
Introduction: The global “obesity epidemic” has thrust nonalcoholic steatohepatitis (NASH) and the metabolic syndrometo the forefront of health-related concerns, and both are linked to the rising incidence of…
alcoholic steatohepatitis is an intermediate link in the transformation from non-alcoholic fatty liver disease to non-alcoholic cirrhosis. Jianpi Shenshi Jiangzhuo formula, an effective prescription for treating…
alcoholic steatohepatitis (NASH) is determined as the fatty liver with inflammation and fibrosis that resembles the alcoholic liver disease without the history of alcohol ingestion. Genetic and environmental factors
Background. Ethanol, tobacco-specific nitrosamine ketone (NNK), and ethanol+NNK exposures cause steatohepatitis, suggesting that smoking can be a cofactor in alcoholic liver disease. Study design. We used MALDI…
availability of reliable non-alcoholic steatohepatitis (NASH) is crucial for the elucidation of its pathogenesis and evaluation of therapeutic candidates. The widely used high-fat high-Calorie (HFC) diet induces…
encoded by Slc2a2 gene plays a key role in glycemic homeostasis. The non-alcoholic steatohepatitis (NASH) is associated with insulin resistance, diabetes and obesity, situations that could induce alteration ... knowing…
fructose-induced obesity leads to an inflammatory and oxidative condition that promotes non-alcoholic steatohepatitis (NASH) development. We investigate the role of the hepatocyte HO-1-SIRT1 axis in attenuating…
most common forms of chronic liver disease which may progress to non-alcoholic steatohepatitis (NASH). Currently there are no therapeutic strategies for such disease. Only lifestyle modification through diet
most common forms of chronic liver disease which may progress to Non-Alcoholic Steatohepatitis (NASH). Currently there are no therapeutic strategies for such disease. Only lifestyle modification through diet
Background: Nonalcoholic steatohepatitis is the inflammatory subtype of nonalcoholic fatty liver disease with high-risk progress to liver fibrosis. We investigated metabolic steatohepatitis with advanced liver fibrosis…
manifestation of the metabolic syndrome, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) arise as serious health burden with alarming global prevalence. The disease complex is currently
Objective: Patients with nonalcoholic steatohepatitis (NASH) are at risk for developing cirrhosis and hepatic cancer. Currently, the definitive gold-standard method of diagnosing NASH is a liver biopsy, an invasive
Aims: The incidences of end-stage liver disease and hepatocellular carcinoma arising from nonalcoholic steatohepatitis (NASH) are rapidly increasing. Although weight reduction is recommended as an initial treatment, no…
alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD) and is usually associated with overweight, obesity and metabolic syndrome. The major treatment offered for NAFLD
alcoholic steatohepatitis (NASH) increases the cardiovascular risk regardless of risk factors in metabolic syndrome. The stroke-prone (SP) spontaneously hypertensive rats (SHRSP5/Dmcr), fed a high-fat and -cholesterol
BACKGROUND Nonalcoholic steatohepatitis (NASH) represents only a part of a wide spectrum of non-alcoholic fatty liver disease (NAFLD) and its prevalence is only 2-3% in the general population
Necrosis Factor-α (TNF-α) in the liver tissue of mice with Non-Alcoholic Steatohepatitis (NASH) and its role in NASH progression. Fifteen healthy male C57BL/6J mice were randomly
benign hepatic steatosis and the hepatic steatosis associated with inflammatory infiltrates, the Non-Alcoholic Steatohepatitis (NASH). NASH may lead to liver cirrhosis and to Hepatocellular Carcinoma (HCC) and about…
West Virginia children, as well as insulin resistance (IR), is wellestablished contributors to nonalcoholic steatohepatitis (NASH). Progression of NASH can lead to hepatic fibrosis and cirrhosis, making early detection…
were enrolled. All patients were classified as having nonalcoholic fatty liver (NAFL) or nonalcoholic steatohepatitis (NASH) on the basis of Matteoni’s classification. Obesity was defined as a body mass
present a case of Nonalcoholic Steatohepatitis (NASH) occurring in combination with sleep apnea syndrome (SAS) in a 35-year-old man whose liver function improved on introduction of continuous positive
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.